Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes

Medical Hypotheses

Volumn 68, Issue 3, 2007, Pages 607-619

  Barbeau, William E ^a   Bassaganya Riera, Josep ^a   Hontecillas, Raquel ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; DIPEPTIDYL PEPTIDASE IV; FAS ANTIGEN; GLIADIN; GLUTEN; GLUTENIN; HLA DQ ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PANCREAS ISLET CELL ANTIBODY; PERFORIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; VITAMIN D;

AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; APOPTOSIS; ARTICLE; CATALYSIS; CELL DESTRUCTION; CELL MIGRATION; CYTOTOXICITY; DENDRITIC CELL; ENVIRONMENTAL FACTOR; ENZYME SYNTHESIS; FOOD INTAKE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; LYMPH NODE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; SMALL INTESTINE; SUN EXPOSURE; TIGHT JUNCTION; UPREGULATION; VITAMIN BLOOD LEVEL; X RAY CRYSTALLOGRAPHY;

DIABETES MELLITUS, TYPE 1; DIETARY PROTEINS; GLUTENS; HUMANS; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS;

BACTERIA (MICROORGANISMS); TRITICUM AESTIVUM;

EID: 33845922975     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.07.052     Document Type: Article

References (150)

1. Barera G., Bonfanti R., Viscardi M., et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 109 (2002) 833-838
2. Hansen D., Bennedbaek F.N., Hansen L.K., et al. High prevalence of coeliac disease in Danish children with type 1 diabetes mellitus. Acta Paediatr 90 (2001) 1238-1243
3. Larsen C.E., and Alper C.A. The genetics of HLA-associated disease. Curr Opin Immun 16 (2004) 660-667
4. Ascher H. Coeliac disease and type 1 diabetes: an affair still with much hidden behind the veil. Acta Paediatr 90 (2001) 1217-1225
5. Louka A.S., and Sollid L.M. HLA in coeliac disease: unraveling the complex genetics of a complex disorder. Tissue Antigens 61 (2003) 105-117
6. Troncone R., and Auricchio S. Gluten-sensitive enteropathy (celiac disease). Food Rev Int 7 (1991) 205-231
7. Pastore M.-.R., Bazzigaluppi E., Belloni C., Arcovio C., Bonifacio E., and Bosi E. Six months of gluten-free diet do not influence antibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab 88 (2003) 162-165
8. Ventura A., Magazzu G., Greco L., et al. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 117 (1999) 297-303
9. Banin P., Perretta R., Ravaioli E., and De Sanctis V. Regression of autoimmunity and abnormal glucose homeostasis in an adolescent boy with silent coeliac disease. Acta Paediatr 91 (2002) 1141-1143
10. Hoorfar B.J., Buschard K., Dagnaes-Hansen F., et al. Prophylactic nutritional modification of diabetes in autoimmune non-obese diabetic (NOD) mice. Brit J Nutr 69 (1993) 597-607
11. Scott F.W. Food-induced type 1 diabetes in the BB rat. Diabetes Metab Rev 12 (1996) 341-359
12. Ziegler A.-G., Schmid S., Huber D., Hummel M., and Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290 (2003) 1721-1728
13. Norris J.M., Barriga K., Klingensmith G., et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA 290 (2003) 1713-1720
14. Savilahti E., Ormala T., Saukkonen T., et al. Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation. Clin Exp Immunol 116 (1999) 70-77
15. Westerholm-Ormio M., Vaarala O., Pihkala P., Ilonen J., and Savilahti E. Immunological activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 52 (2003) 2287-2295
16. Auricchio R., Paparo F., Maglio M., et al. In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes 53 (2004) 1680-1683
17. Gilbert S.M., Wellner N., Belton P.S., et al. Expression and characterisation of a highly repetitive peptide derived from a wheat seed storage protein. Biochim Biophys Acta 1479 (2000) 135-146
18. Tatham A.S., Drake A.F., and Shewry P.R. Conformational studies of a synthetic peptide corresponding to the repeat motif of C hordein. Biochem J 259 (1989) 471-476
19. Shan L., Molberg Q., Parrot I., et al. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
20. De Meester I., Durinx C., Bal G., et al. Natural substrates of dipeptidyl peptidase IV. In: Langner J., and Ansorge S. (Eds). Cellular peptidases in immune functions and diseases 2 (2000), Plenum Publishers 67-87
21. Dong R.-P., and Morimoto C. Role of CD26 for CD4 memory T cell function and activation. Hum Cell 9 (1996) 153-162
22. Drucker D.J. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17 (2003) 161-171
23. Wang Q., Li L., Xu E., Wong V., Rhodes C., and Brubaker P.L. Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia 47 (2004) 478-487
24. Cho Y.R., and Kim C.W. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation. Biochem Biophys Res Commun 314 (2004) 773-780
25. Yan S., Marguet D., Dobers J., Reutter W., and Fan H. Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen. Eur J Immunol 33 (2003) 1519-1527
26. Tanaka T., Kameoka J., Yaron A., Schlossman S.F., and Morimoto C. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90 (1993) 4586-4590
27. Fleisher B. CD26; a surface protease involved in T-cell activation. Immunol Today 15 (1994) 180-183
28. Struyf S., De Meester I., Scharpe S., et al. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur J Immunol 28 (1998) 1262-1271
29. Lim J.K., Burns J.M., Lu W., and DeVico A.L. Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5. J Leukoc Biol 78 (2005) 1-11
30. Lynch E.A., Heijens C.A.W., Horst N.F., Center D.M., and Cruikshank W.W. Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5. J Immunol 171 (2003) 4965-4968
31. Karlsson Faresjo M.G.E., Ernerudh J., and Ludvigsson Et J. Cytokine profile in children during the first 3 months after diagnosis of type 1 diabetes. Scand J Immunol 59 (2004) 517-526
32. Ott P.A., Herzog B.A., Quast S., et al. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls. Clin Immunol 115 (2005) 102-114
33. Asmar R.E., Panigrahi P., Bamford P., et al. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 123 (2002) 1607-1615
34. Clemente M.G., De Virgilis S., Kang J.S., et al. Early effects of gliadin on enterocyte intracellular signaling involved in intestinal barrier function. Gut 52 (2003) 218-223
35. Scott F.W., Cloutier H.E., Kleemann R., et al. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats. Diabetes 46 (1997) 589-598
36. Meddings J.B., Jarand J., Urbanski S.J., Hardin J., and Gall D.G. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 276 (1999) G951-G957 Gastrointest Liver Physiol 39
37. Watts T., Berti I., Sapone A., et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type 1 diabetes in the BB diabetic-prone rats. Proc Natl Acad Sci 102 (2005) 2916-2921
38. Mooradian A.D., Morley J.E., Levine A.S., Prigge W.F., and Gebhard R.L. Abnormal intestinal permeability to sugars in diabetes mellitus. Diabetologia 29 (1986) 221-224
39. Carratu R., Secondulfo M., de Magistris L., et al. Altered intestinal permeability to mannitol in diabetes mellitus type 1. J Pediatr Gastroenterol Nutr 28 (1999) 264-269
40. *02 allele. Autoimmunity 35 (2002) 365-368
41. Secondulfo M., Iafusco D., Carratu R., et al. Ultrastructural mucosal alterations and increased permeability in non-celiac, type 1 diabetic patients. Dig Liver Dis 36 (2004) 35-45
42. Damci T., Nuhoglu I., Devranoglu G., Osar Z., Demir M., and Ilkova H. Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in type 1 diabetic patients. Eur J Clin Invest 33 (2003) 397-401
43. Zeng Z.-H., Castano A.R., Segelke B.W., Stura E.A., Peterson P.A., and Wilson I.A. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277 (1997) 339-345
44. Godfrey D.I., Pellicci D.G., and Smyth M.J. The elusive NKT cell antigen - is the search over?. Science 306 (2004) 1687-1689
45. Moody D.B., and Besra G.S. Glycolipid targets of CD1-mediated T-cell responses. Immunology 104 (2001) 243-251
46. Joyce S., Woods A.S., Yewdell J.W., et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279 (2003) 1541-1544
47. Tangri S., Brossay L., Burdin N., Lee D.J., Corr M., and Kronenberg M. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing. Proc Natl Acad Sci USA 95 (1998) 14314-14319
48. Castano A.R., Tangri S., Miller J.E.W., et al. Peptide binding and presentation by mouse CD1. Science 269 (1995) 223-226
49. 2-microglobulin-associated form. Int Immunol 11 (1998) 383-392
50. van de Wal Y., Corazza N., Allez M., et al. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology 124 (2003) 1420-1431
51. Rocher A., Soriano F., Molina E., Gonzalez-Limas G., and Mendez E. Characterization of distinct α- and γ-type gliadins and low molecular weight components from wheat endosperm as coeliac immunoreactive proteins. Biochim Biophys Acta 1247 (1995) 143-148
52. Oikawa Y., Shimada A., Yamada S., et al. NKT cell frequency in Japanese type 1 diabetes. Ann NY Acad Sci 1005 (2003) 230-232
53. + thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 180 (1994) 423-432
54. Ganset J.L., Kiebler V., Engele M., et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol 170 (2003) 3154-3161
55. Lee P.T., Benlagha K., Teyton L., and Bendelac A. Distinct functional lineages of human Vα24 natural killer T cells. J Exp Med 195 (2002) 637-641
56. Laloux V., Beaudoin L., Jeske D., Carnaud C., and Lehuen A. NK T cell-induced protection against diabetes in Vα14-Jα281 transgenic nonobese diabetic mice is associated with a TH2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J Immunol 166 (2001) 3749-3756
57. Naumov Y.N., Bahjat K.S., Gausling R., et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. PNAS 98 (2001) 13838-13843
58. Wilson S.B., Kent S.C., and Patton K.T. Extreme TH1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391 (1998) 177-181
59. Wilson S.B., Kent S.C., Horton H.F., et al. Multiple differences in gene expression in regulatory Vα24JαQ T cells from identical twins discordant for type 1 diabetes. PNAS 97 (2000) 7411-7416
60. Barbeau W.E. Interactions between dietary proteins and the human system; implications for oral tolerance and food-related diseases. Adv Exp Med Biol 415 (1997) 183-193
61. - T cells. γδ T cell receptor-positive T cells from nude mice abrogate oral tolerance. J Immunol 143 (1989) 3415-3422
62. + T cells provide B cell help. J Exp Med 175 (1992) 695-707
63. Ishimitsu R., Yajima T., Nishimura H., Kawauchi H., and Yoshikai Y. NKT cells are dispensable in the induction of oral tolerance but are indispensable in the abrogation of oral tolerance by prostaglandin E. Eur J Immunol 33 (2003) 183-193
64. Trudeau J.D., Dutz J.P., Arany E., Hill D.J., Fieldus W.E., and Finegood D.T. Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?. Diabetes 49 (2000) 1-7
65. Turley S., Poirot L., Hattori M., Benoist C., and Mathis D. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med 198 (2003) 1527-1537
66. Kassem S.A., Ariel I., Thornton P.S., Scheimberg I., and Glaser B. β-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49 (2000) 1325-1333
67. Huang F.-P., Platt N., Wykes M., et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 191 (2000) 435-443
68. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188 (1998) 1359-1368
69. Ip W.-K., and Lau Y.-L. Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J Immunol 173 (2004) 189-196
70. Liu L.M., and MacPherson G.G. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime nai{dotless}̈ve T cells in vivo. J Exp Med 177 (1993) 1299-1307
71. Pavli P., Woodhams C.E., Doe W.F., and Hume D.A. Isolation and characterization of antigen-presenting dendritic cells from the mouse intestinal lamina propria. Immunology 70 (1990) 40-47
72. Liu L.M., and MacPherson G.G. Lymph-borne (veiled) dendritic cells can acquire antigen and present intestinally administered antigens. Immunology 73 (1991) 281-286
73. MacPherson G.G., Jenkins C.D., Stein M.J., and Edwards C. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J Immunol 154 (1995) 1317-1322
74. Luther S.A., Bidgol A., Hargreaves D.C., et al. Differing activities of hemeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 169 (2002) 424-433
75. Bouma G., Coppens J.M.C., Mourits S., et al. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. Eur J Immunol 35 (2005) 2386-2396
76. Gagnerault M.-C., Luan J.J., Lotton C., and Lepault F. Pancreatic lymph nodes are required for priming of β cell reactive T cells in NOD mice. J Exp Med 196 (2002) 369-377
77. Fabien N., Bergerot I., Maguer-Satta V., Orgiazzi J., and Thivolet C. Pancreatic lymph nodes are early targets of T cells during adoptive transfer of diabetes in NOD mice. J Autoimmun 8 (1995) 323-334
78. Clare-Salzler M., and Mullen Y. Marked dendritic cell-T cell cluster formation in the pancreatic lymph node of the non-obese diabetic mouse. Immunology 76 (1992) 478-484
79. Voorbij H.A.M., Jeucken P.H.M., Kabel P.J., De Haan M., and Drexhage H.A. Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes 38 (1989) 1623-1629
80. Jaakkola I., Jalkanen S., and Hanninen A. Diabetogenic T cells are primed both in the pancreatic and gut-associated lymph nodes in NOD mice. Eur J Immunol 33 (2003) 3255-3264
81. + T cell-mediated insulin-dependent diabetes mellitus. J Immunol 163 (1999) 4335-4341
82. + T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways. Eur J Immunol 27 (1997) 415-420
83. Goldrath A.W., Barber L., Chen K.E., and Alters S.E. Differences in adhesion markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse. J Autoimmun 8 (1995) 209-220
84. Hosszufalusi N., Chan E., Granger G., and Charles M.A. Quantitative analyses comparing all major spleen cell phenotypes in BB and normal rats; Autoimmune imbalance and double negative T cells associated with resistant, prone and diabetic animals. J Autoimmun 5 (1992) 305-318
85. Santamaria P., Nakhleh R.E., Sutherland D.E., and Barbosa J.J. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 41 (1992) 53-61
86. Santaria P., Lewis C., Jessurun J., Sutherland D.E.R., and Barbosa J.J. Skewed T-cell receptor usage junctional and heterogeneity among isletitis αβ and γδ T-cells in human IDDM. Diabetes 43 (1994) 599-606
87. high-lymphocytes in nonobese diabetic mice. Blood 88 (1996) 934-944
88. high) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes 45 (1996) 1173-1180
89. Fabien N., Bergerot I., Orgiazzi J., and Thivolet C. Lymphocyte function associated antigen-1, integrin α4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes 45 (1996) 1181-1186
90. Hanninen A., Jaakkola I., and Jalkanen S. Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J Immunol 160 (1998) 6018-6025
91. Hanninen A., Taylor C., Streeter P.R., et al. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 92 (1993) 2509-2515
92. Hanninen A., Salmi M., Simell O., and Jalkanen S. Endothelial cell-binding properties of lymphocytes infiltrated in human diabetic pancreas. Implications for pathogenesis of IDDM. Diabetes 42 (1993) 1656-1662
93. Hanninen A., Jalkanen S., Salmi M., Toikkanen S., Nikolakaros G., and Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90 (1992) 1901-1910
94. Undlein D.E., and Thorsby E. HLA associations in type 1 diabetes: merging genetics and immunology. Trends Immunol 22 (2001) 467-469
95. β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329 (1987) 599-604
96. Sheehy M.J., Scharf S.J., Rowe J.R., et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 83 (1989) 830-835
97. Gillespie K.M., Bain S.C., Barnett A.H., et al. The rising incidence of diabetes and reduced contribution of high-risk HLA-haplotypes. Lancet 364 (2004) 1699-1700
98. Lambert A.P., Gillespie K.M., Thomson G., et al. Absolute risk of childhood-onset diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 89 (2004) 4037-4043
99. *04 variants to predisposition to or protection from insulin dependent diabetes mellitus is independent of DQ. J Autoimmun 9 (1996) 411-414
100. Undlien D.E., Friede T., Rammensee H.G., et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 46 (1997) 143-149
101. *0401 affect susceptibility to type 1 diabetes?. Genes Immun 6 (2005) 298-304
102. Caillat-Zucman S., Garchon H.-J., Timsit J., et al. Age dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90 (1992) 2242-2250
103. Bottazzo G.F., Dean B.M., McNally J.M., MacKay E.H., Swift P.G., and Gamble D.R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313 (1985) 353-360
104. Foulis A.K., and Farquharson M.A. Aberrant expression of HLA-DR antigens by insulin-containing β-cells in recent-onset type 1 diabetes mellitus. Diabetes 35 (1986) 1215-1224
105. Geluk A., van Meijgaarden K.E., Schloot N.C., Drijfhout J.W., Ottenhoff T.H.M., and Roep B.O. HLA-DR binding analysis of peptides from islet antigens in IDDM. Diabetes 47 (1998) 1594-1601
106. Paronen J., Klemetti P., Kantele J.M., et al. Glutamate decarboxylase-reactive peripheral lymphocytes from patients with IDDM express gut-specific homing receptor α4β7-integrin. Diabetes 46 (1997) 583-588
107. Pomeranz Y. Functional properties of food components. 2nd ed. (1991), Academic Press, Inc., San Diego (CA)
108. Bu D.-F., Erlander M.G., Hitz B.C., et al. Two human glutamate decarboxylases, g5-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89 (1992) 2115-2119
109. MacFarlane A.J., Burghardt K.M., Kelly J., et al. A type 1 diabetes-related protein from wheat (Triticum aestivum). J Biol Chem 278 (2003) 54-63
110. Dobersen M.J., Scharff J.E., Ginsberg-Fellner F., and Notkins A.L. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 303 (1980) 1493-1498
111. Rittenhouse H.G., Oxender D.L., Pek S., and Ar D. Complement-mediated cytotoxicity effects on pancreatic islets with sera from diabetic patients. Diabetes 29 (1980) 317-322
112. Radillo O., Nocera A., Leprini A., et al. Complement-fixing islet cell antibodies in type-1 diabetes can trigger the assembly of the terminal complement complex on human islet cells and are potentially cytotoxic. Clin Immunol Immunopathol 79 (1996) 217-223
113. Zhao H.X., Stenhouse E., Sopert C., et al. Incidence of childhood-onset type 1 diabetes mellitus in Devon and Cornwall, England, 1975-1996. Diabet Med 16 (1999) 1030-1035
114. Mooney J.A., Helms P.J., Jolliffe I.T., and Smail P. Seasonality of type 1 diabetes mellitus in children and its modifications by weekends and holidays: retrospective observational study. Arch Dis Child 89 (2004) 970-973
115. Nystrom L., Dahlquist G., Ostman J., et al. Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 years of age: indications of climatological determinants for age at onset. Int J Epidemiol 21 (1992) 352-358
116. Tuomilehto J., Podar T., Brigis G., et al. Comparison of the incidence of insulin-dependent diabetes mellitus in childhood among five Baltic populations during 1983-1988. Int J Epidemiol 21 (1992) 518-527
117. Xin-Hua L., Tian-Lin L.I., Ze Y., et al. A nine-year prospective study on the incidence of childhood type 1 diabetes mellitus in China. Biomed Environ Sci 13 (2000) 263-270
118. Staples J.A., Ponsonby A.-L., Lim L.L.-Y., and McMichael A.J. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ Health Perspect 111 (2003) 518-523
119. Dahlquist G., and Mustonen L. Childhood onset diabetes - time trends and climatological factors. Int J Epidemiol 23 (1994) 1234-1241
120. Hypponen E., Laara E., Reunanen A., Jarvelin M.-R., and Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358 (2001) 1500-1503
121. 3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51 (2002) 1367-1374
122. Manetti R., Parronchi P., Giudizi M.G., et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 177 (1993) 1199-1204
123. Kobayashi M., FitZ L., Ryan M., et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170 (1989) 827-845
124. D'Andrea A., Rengaraju M., Valiante N.M., et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176 (1992) 1387-1398
125. Trembleau S., Germann T., Gately M.K., and Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 16 (1995) 383-386
126. Fujihira K., Nagata M., Moriyama H., et al. Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice. Diabetes 49 (2000) 1998-2006
127. 3. J Clin Invest 101 (1998) 252-262
128. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., and Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol Cell Biol 15 (1995) 5258-5267
129. Chang T.-J., Lei H.-H., Yeh J.-I., et al. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol 52 (2000) 575-580
130. Motohashi Y., Yamada S., Yanagawa T., et al. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab 88 (2003) 3137-3140
131. Kolb H., and Elliott R.B. Increasing incidence of IDDM a consequence of improved hygiene?. Diabetologia 37 (1994) 729-731
132. Kukreja A., and MacLaren N.K. NKT cells and Type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates. Diabetes Technol Therap 4 (2002) 323-333
133. Patterson C.C., Carson D.J., and Hadden D.R. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Diabetologia 39 (1996) 1063-1069
134. Gibbon C., Smith T., Egger P., Betts P., and Phillips D. Early infection and subsequent insulin dependent diabetes. Arch Dis Child 77 (1997) 384-385
135. Feillet H., and Bach J.-F. On the mechanisms of the protective effect of infections on type 1 diabetes. Clin Dev Immunol 11 (2004) 191-194
136. Martins T.C., and Aguas A.P. Mechanisms of Mycobacterium avum-induced resistance against insulin-dependent diabetes mellitus (IDDM) in on-obese diabetic (NOD) mice: role of FAS and Th1 cells. Clin Exp Immunol 115 (1999) 248-254
137. Oldstone M.B.A. Prevention of type 1 diabetes in nonobese diabetic mice by virus infection. Science 239 (1988) 500-502
138. Wilberz S., Partke H.J., Dagnaes-Hansen F., and Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 34 (1991) 2-5
139. Zaccone P., Fehervari Z., Jones F.M., et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 33 (2003) 1439-1449
140. Wu D., Xing G.-W., Poles M.A., et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci 102 (2005) 1351-1356
141. Faveeuw C., Angeli V., Fontaine J., et al. Antigen presentation by CD1d contributes to the amplication of Th2 responses to Schistosoma mansoni glycoconjugates in mice. J Immunol 169 (2002) 906-912
142. Bach J.-F. Protective role of infections and vaccinations on autoimmune diseases. J Autoimmun 16 (2001) 347-353
143. Sharif S., Arreaza G.A., Zucker P., et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and reoccurrence of autoimmune type 1 diabetes. Nature Med 7 (2001) 1057-1062
144. Weber S.E., Harbertson J., Godebu E., et al. Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J Immunol 176 (2006) 4730-4739
145. Peakman M., Alviggi L., Hussain M.J., et al. Increased expression of T-cell markers of immunological memory associated with protection from type 1 diabetes. A study of identical twins. Diabetes 43 (1994) 712-717
146. Redondo M.J., Yu L., Hawa M., et al. Heterogeneity of type 1 diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44 (2001) 354-362
147. Olmos P., A'Hern R., Heaton D.A., et al. The significance of the concordance rate of type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31 (1988) 747-750
148. Kaprio J., Tuomilehto J., Koskenvuo M., et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35 (1992) 1060-1067
149. Verge C.F., Gianani R., Yu L., et al. Late progression to diabetes and evidence for chronic β-cell autoimmunity in identical twins of patients with type 1 diabetes. Diabetes 44 (1995) 1176-1179
150. Feltbower R.G., Bodansky H.J., McKinney P.A., Houghton J., Stephenson C.R., and Haigh D. Trends in the incidence of childhood diabetes in South Asians and other children in Bradford, UK. Diabet Med 19 (2002) 162-166